Pharmacokinetics of cefamandole in infants and children
- PMID: 708009
- PMCID: PMC352456
- DOI: 10.1128/AAC.14.3.315
Pharmacokinetics of cefamandole in infants and children
Abstract
In infants less than 3 months of age, the serum concentration of cefamandole during therapy was higher and more prolonged than that in children older than 1 year. A dosage of 37 mg/kg administered intravenously at 6-h intervals provided a serum concentration in excess of the minimum inhibitory concentrations of common bacterial pathogens for 4 h, and in young infants for 5 h, after dosing.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
